Minimal standards for the performance and interpretation of toxicology tests in legal proceedings

Journal of Forensic Sciences

Volumn 44, Issue 3, 1999, Pages 516-522

  Wu, Alan H B ^a   Hill, Dennis W ^b   Crouch, Dennis ^c   Hodnett, C Nicholas ^d   McCurdy, H Horton ^e  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c Biomedical Polymers Research Bldg   (United States)

^d Westchester County Department of Laboratories and Research   (United States)

^e Georgia Bureau of Investigation   (United States)

Author keywords

Drugs of abuse testing; Enzyme immunoassay; Forensic science; Gas chromatography mass spectrometry (GC MS); Signal to noise ratio

Indexed keywords

ARTICLE; BODY FLUID; CRIMINAL JUSTICE; ENZYME IMMUNOASSAY; GAS CHROMATOGRAPHY; HUMAN; LABORATORY DIAGNOSIS; LAW SUIT; LEGAL ASPECT; MASS SPECTROMETRY; PRIORITY JOURNAL; SIGNAL NOISE RATIO; SUBSTANCE ABUSE; TOXICITY TESTING;

BLOOD STAINS; CLOTHING; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IMMUNOASSAY; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STREET DRUGS; TOXICOLOGY;

EID: 0032924262     PISSN: 00221198     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Department of Health and Human Services. Mandatory guidelines for Federal workplace drug testing programs; final guidelines notice. Fed Register 1988;53:11969-89.
2. Childs PS, McCurdy HH. Evaluation of a radioimmunoassay (125I) kit for cannabinoid metabolites in urine and whole blood. J Anal Toxicol 1984;8:220-3.
3. Lewellen LJ, McCurdy HH. A novel procedure for the analysis of drugs in whole blood by homogeneous enzyme immunoassay (EMIT). J Anal Toxicol 1988;12:260-4.
4. Rattenbury JM, Taylor T. Measurement of theophylline in dried blood spots by spectrophotometric enzyme immunoassay. Ann Clin Biochem 1988;25:650-3.
5. Bergqvist Y, al Kabbani J, Krysen B, Berggren Palme I, Rombo L. High-performance liquid chromatographic method for the simultaneous determination of mefloquine and its carboxylic metabolite in 100-microliters capillary blood samples dried on paper. J Chromatogr 1993;615: 297-302.
6. DuBey IS, Caplan YH. The storage of forensic urine drug specimens as dry stains: recovery and stability. J Forensic Sci 1996;41:845-50.
7. Linder MW, Valdes R. Mechanism and elimination of aspirin-induced interference in Emit II d.a.u. assays. Clin Chem 1994;40:1512-6.
8. Wagener RE, Linder MW, Valdes R. Decreased signal in Emit assays of drugs of abuse in urine after ingestion of aspirin: potential for false-negative results. Clin Chem 1994;40:608-12.
9. Laboratory Inspector Training Manual for the National Laboratory Certification Program. Rockville, MD: U.S. Department of Health and Human Services, Publication No. (ADM) 91-1796, 1991;N-16.
10. Field PH. Quality assurance and proficiency testing. In: Cravey RH, Baselt RC, editors. Introduction to forensic toxicology. Davis, CA: Biomedical Publications, 1981;183.
11. Armbruster DA, Tillman MD, Hubbs LM. Limit of detection (LOD)/limit of quantitation (LOQ): comparison of the empirical and statistical methods exemplified with GC-MS assays of abused drugs. Clin Chem 1994;40:1233-8.
12. Underwood PJ, Kananen GE, Armitage EK. A practical approach to determination of laboratory GC-MS limits of detection. J Anal Toxicol 1998;21:12-6.
13. Kapur BM. Drug-testing methods and clinical interpretations of test results. Bull Narc 1993;45:115-54.
14. Huestis MA, Henningfield JE, Cone EJ. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol 1992;16:276-82.
15. Ambre J. The urinary excretion of cocaine and metabolites in humans: a kinetic analysis of published data. J Anal Toxicol 1085;9:241-5.
16. Dubowski KM. Alcohol determination in the clinical laboratory. Am J Clin Pathol 1980;74:747-50.
17. Dubowski KM. The role of the scientist in litigation involving drug-use testing. Clin Chem 1988;34:788-92.
18. 9-tetrahydrocannabinol and two major metabolites in physiological specimens using capillary column gas chromatography negative ion chemical ionization mass spectrometry. Biol Mass Spectrom 1983;10:316-23.
19. Savitzky A, Golay MJE. Smoothing and differentiation of data by simplified least squares procedures. Anal Chem 1964;36:1627-39.
20. Foltz R. Analysis of cannabinoids in physiological specimens by gas chromatography/mass spectrometry. In: Baselt RC, editor. Advances in Analytical Toxicology, Vol. 1, Foster City, CA, Biomedical Publications, 1984;125-57.
21. McBurney LJ, Bobbie BA, Sepp LA. GC/MS and EMIT analyses for delta 9-tetrahydrocannabinol metabolites in plasma and urine of human subjects. J Anal Toxicol 1986;10:56-64.
22. Wu AHB. Mechanism of interferences for gas chromatography/mass spectrometry analysis of urine for drugs of abuse. Ann Clin Lab Sci 1995;25:319-29.
23. Peat MA. Guest editorial. J Forensic Sci 1997;42:775.